Company intelligence / Profile preview

Neola Medical

Ownership: Private
Development stage: Preclinical

Overview

Neola® has demonstrated safety and efficacy as a non-invasive continuous lung monitoring device for preterm infants. It uses laser spectroscopy to provide real-time data on lung volume changes and oxygen concentration. The company has received CB certification for IEC 60601 standards and ISO 13485 quality management certification. Clinical studies are ongoing or planned with leading U.S. hospitals to support regulatory approval and market launch.

Therapeutic areas: PulmonologyOther
Modalities: DeviceNon-pharmacological therapy (continuous lung monitoring device)
Industry: Physiological Monitoring

Partnerships

Stanford Impact1 program collaboration supported by the FDA for pediatric innovation acceleration

Beyond the preview

Go deeper on Neola Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Neola Medical.

Explore the full profile